Clinical emergence of on-target WRN mutations during Werner helicase inhibitor therapy in MSI colorectal cancer
European Journal of Cancer · 2026-11 · 248 · 117533
DOI: 10.1016/j.ejca.2026.117533 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cancer, 2026-11. Verfasst von G. Picco und 9 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Picco, G., Vibert, J., Walker, S., Bhosle, S., Garcia-Casado, M., Jeanson, A., Colmet-daage, L., Foote, M., Postel-Vinay, S., & Garnett, M. (2026). Clinical emergence of on-target WRN mutations during Werner helicase inhibitor therapy in MSI colorectal cancer. European Journal of Cancer, 248, 117533. https://doi.org/10.1016/j.ejca.2026.117533
Vancouver
Picco G, Vibert J, Walker S, Bhosle S, Garcia-Casado M, Jeanson A, et al. Clinical emergence of on-target WRN mutations during Werner helicase inhibitor therapy in MSI colorectal cancer. European Journal of Cancer. 2026;248:117533. doi:10.1016/j.ejca.2026.117533
BibTeX
@article{Picco2026,
author = {Picco, G. and Vibert, J. and Walker, S.J. and Bhosle, S. and Garcia-Casado, M. and Jeanson, A. and Colmet-daage, L. and Foote, M.B. and Postel-Vinay, S. and Garnett, M.},
title = {Clinical emergence of on-target WRN mutations during Werner helicase inhibitor therapy in MSI colorectal cancer},
journal = {European Journal of Cancer},
year = {2026},
volume = {248},
pages = {117533},
doi = {10.1016/j.ejca.2026.117533}
}
EUVIMED